Why is "Muscular dystrophy" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-08-08 02:55:06
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Muscular_dystrophy entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-08-08 and was most recently seen on 2026-08-08.
Wikipedia Overview
Muscular dystrophy (MD) is a genetically and clinically heterogeneous group of rare neuromuscular diseases that cause progressive weakness and breakdown of skeletal muscles over time. The disorders differ as to which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Some types are also associated with problems in other organs.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Exclusive | Muscular Dystrophy Nonprofit Seeks to Boost Venture-Capital Program - WSJ
-
Centralia Firemen raise $1,650 for Muscular Dystrophy - southernillinoisnow.com
-
Hingham man marks 50 years of fundraising for Muscular Dystrophy Association - Boston 25 News
-
The power and impact of the Muscular Dystrophy Association (MDA): Changing lives, creating hope - WGN Radio 720
-
New blood biomarkers reveal how common muscular dystrophy treatment may impair overall growth - Binghamton University
-
Looking back at the Jerry Lewis Muscular Dystrophy Telethon after 60 years - CBS News
-
Brothers run marathons on 2 legs, 3 wheels for Muscular Dystrophy awareness - WIVB News 4
-
Cleveland firefighters kick off 'Fill the Boot' campaign, aiming to raise $80,000 for muscular dystrophy research - WKYC
-
Palm Beach County firefighters fundraising drive for muscular dystrophy - WPBF
-
Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study - Vanderbilt Health News
-
Changing my mindset about Duchenne led me to new friends - Muscular Dystrophy News
-
Palm Beach County firefighters kick off annual Fill the Boot drive for Muscular Dystrophy - cbs12.com
-
United Family begins annual ‘Aisles of Smiles’ campaign for Muscular Dystrophy - NewsChannel 10
-
Muscular Dystrophy Mutations Leave Cells Short of "Packing Peanuts" - UC Davis College of Biological Sciences
-
FDA Extends Deramiocel Review for Duchenne Muscular Dystrophy - CGTLive®
-
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy - Nature
-
Drug for Duchenne muscular dystrophy to become available in Georgia early next week - jam-news.net
-
Hingham man marks 50 years of fundraising for Muscular Dystrophy Association - Boston 25 News
-
IDISCY holding 3rd annual charity walk to help people with muscular dystrophy - CBS News
-
Phase 3 trial shows investigational cell therapy slowed disease progression in Duchenne muscular dystrophy - UC Davis Health
-
'Fill the Boot': Cleveland firefighters kick off campaign to raise $80,000 for muscular dystrophy research - WKYC
-
"Fill the Boot" this weekend in Mason City to raise money for muscular dystrophy research - kaaltv.com
-
DMD Potential Therapy Preserves Heart, Arm Function - Cedars-Sinai
-
‘Leaky’ Muscle Fibers Drive Immune Response in Muscular Dystrophy - news.feinberg.northwestern.edu
-
Fill the Boot beats the heat, raising $1,700 - morningsentinel.com
-
East Lansing firefighters raising money for muscular dystrophy - WILX
-
Treating Duchenne muscular dystrophy before symptoms emerge may improve motor function, clinical trial suggests - Medical Xpress
-
Novel gene therapy platform restores muscle function in models of Duchenne muscular dystrophy - UT MD Anderson
-
PPMD Celebrates World Duchenne Awareness Day, Highlights Importance of Access for Duchenne, Becker Community - Morningstar
-
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial - The Lancet
-
Statement from the Muscular Dystrophy Association on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee Vote on Deramiocel - Muscular Dystrophy Association
-
PPMD to Focus on Equitable Access for Duchenne and Becker Muscular Dystrophy on World Duchenne Awareness Day 2026 - geneonline.com
-
Euclid firefighters will Fill the Boot for muscular dystrophy research, care - Cleveland.com
-
Cardiomyopathy in Duchenne muscular dystrophy is focus of nearly $2M grant - Vanderbilt Health News
-
Duchenne Muscular Dystrophy Cell Therapy Preserves Heart, Muscle Function - respiratory-therapy.com
-
Defining Haplosufficiency in Autosomal Recessive Limb-Girdle Muscular Dystrophy Using Molecular Markers in Disease Carriers - Neurology® Journals
-
Acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business - Servier
-
Muscular Dystrophy Association Launches #MDAstrong - GlobeNewswire
-
Top 10 muscular dystrophy news stories of 2025 - Muscular Dystrophy News
-
Limb girdle muscular dystrophy patients face a maddening reality - STAT
-
Awareness event on Duchenne muscular dystrophy highlights relevance of hydrotherapy - Telegraph India
-
Dyne Therapeutics’ z-rostudirsen Wins Priority Review for Duchenne Muscular Dystrophy - The Clinical Trial Vanguard
-
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business - PR Newswire
-
Canadian fire fighters raise $1.1 million for Muscular Dystrophy Canada - IAFF
-
Inspired by son, Anning offers forward-thinking approach to muscular dystrophy care - Slippery Rock University
-
Phase 3 HOPE-3 Data Reinforce Skeletal and Cardiac Benefits of Deramiocel in Duchenne Muscular Dystrophy - CGTLive®
-
Secretary Kennedy Adds Duchenne Muscular Dystrophy, Metachromatic Leukodystrophy to Newborn Screenings - HHS.gov
-
Unlocking new paths in muscular dystrophy treatment - University of Nevada, Reno
-
Novel gene therapy platform shows promise in Duchenne muscular dystrophy preclinical model - RegMedNet
-
Researchers provide answers to progressive heart problems in muscular dystrophy and potential reversibility - Baylor College of Medicine Blog Network -
-
Impaired stem cell migration and divisions in Duchenne muscular dystrophy revealed by live imaging - Nature
-
Fairhope boy with muscular dystrophy receives wheelchair accessible vehicle from nonprofit - fox10tv.com
-
The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy | Newswise - Newswise
-
Interpreting Long-Term MESA Data of Sevasemten to Treat Becker Muscular Dystrophy - NeurologyLive
-
New Treatment Shows Remarkable Motor Improvements in Boys With Muscular Dystrophy—in Just 12 Weeks - Good News Network
-
The Bonnevilles back muscular dystrophy fundraiser featuring good music and bad shirts - The Irish News
-
HDAC11 protein identified as potential target for Duchenne muscular dystrophy - Drug Target Review
-
Earlier Intervention May Improve Motor Function in Duchenne Muscular Dystrophy | Newswise - Newswise
-
Muscular Dystrophy Association Launches ‘Access the Vote’ Campaign to Empower Disability Community Ahead of Elections - Muscular Dystrophy Association
-
Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio - Muscular Dystrophy Association
-
RNA Toxicity Is a Driver of Heart Disease in Muscular Dystrophy - Inside Precision Medicine
-
Fairhope boy with muscular dystrophy receives wheelchair accessible vehicle from nonprofit - KCRG
-
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy - Contemporary Pediatrics
-
Sevasemten’s Effect on Cardiovascular Markers Indicate Protective Role in Becker Muscular Dystrophy - NeurologyLive
-
Grünenthal receives FDA designations for tegacorat in Duchenne muscular dystrophy - PharmaTimes
-
Muscular Dystrophy Association Marks ALS Awareness Month throughout May with Breakthrough Research, Powerful Stories, and Nationwide Call to Action to End ALS - Muscular Dystrophy Association
-
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug - BioSpace
-
VCU Health launches nation’s first LGMD Center of Excellence - VCU Health
-
Understanding the Pathophysiology of Duchenne Muscular Dystrophy - NeurologyLive
-
Early trial data support RNA therapies for two muscular dystrophy types - Muscular Dystrophy News
-
Looking for community? Join us in the muscular dystrophy forums. - Muscular Dystrophy News
-
Muscular Dystrophy Association Volunteers - KTTC | Rochester, MN
-
Servier inks $2.6B buyout of Edgewise’s muscular dystrophy unit to beef up neurology pipeline - Fierce Biotech
-
How to Navigate School and Workplace Accommodations With Duchenne Muscular Dystrophy - Everyday Health
-
Muscular Dystrophy Association Marks Rare Disease Day by Spotlighting Community Stories Driving Progress in Research, Care, and Advocacy - Muscular Dystrophy Association
-
Stanford students work toward cure for rare muscular dystrophy - Stanford Report
-
Servier frees Edgewise for cardio mission with $2.65B muscular dystrophy deal - BioSpace
-
Drug may protect the heart in people with Duchenne muscular dystrophy - Futurity
-
Seven biotechs driving progress in Duchenne muscular dystrophy - Labiotech.eu
-
Servier buys into muscular dystrophy with potentially $2.7B deal - biopharmadive.com
-
FDA Accepts Sarepta's sNDAs for Casimersen and Golodirsen for Duchenne Muscular Dystrophy - NeurologyLive
-
Muscular Dystrophy Association’s Legacy Awards Honor Innovators in Clinical and Scientific Research, and Community Impact at the 2026 MDA Clinical & Scientific Conference in March - Muscular Dystrophy Association
-
RGX-202 demonstrates positive phase 3 results for Duchenne muscular dystrophy - Contemporary Pediatrics
-
Family of drugs used for treating muscular dystrophy could improve brain tumor treatment - Medical Xpress
-
Novel gene therapy platform restores muscle function in Duchenne muscular dystrophy model - Medical Xpress
-
New era for fighting rare childhood disease: Duchenne Muscular Dystrophy - news4jax.com
-
Servier bets up to $2.7B on Edgewise's muscular dystrophy business - firstwordpharma.com
-
Development of a cost-effectiveness analysis model for Duchenne muscular dystrophy utilizing the national registry in Japan - Nature
-
Muscular Dystrophy Association Names Pamela Kournetas as Chief Financial Officer - Muscular Dystrophy Association
-
Fairhope boy with muscular dystrophy receives wheelchair accessible vehicle from nonprofit - FOX5 Vegas
-
Disease Progression and Quality of Life in Duchenne Muscular Dystrophy - NeurologyLive
-
Senator Collins Recognized by Parent Project Muscular Dystrophy - U.S. Senator Susan Collins (.gov)
-
Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win - BioSpace
-
Fairhope boy with muscular dystrophy receives wheelchair accessible vehicle from nonprofit - AZ Family
-
Expert Consensus on Genetic Diagnostic Approaches for Patients With Limb-Girdle Muscular Dystrophy - Neurology® Journals
-
Boston high schooler with muscular dystrophy advocates for more awareness — and a cure - NBC Boston
-
Family of drugs used for treating muscular dystrophy could improve bra - Brain Tumour Research
-
Muscular Dystrophy Association to Honor UNLV’s Łukasz Sznajder with Inaugural Research Momentum Award - University of Nevada, Las Vegas | UNLV
-
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar - Nature
-
The brothers shared an unbreakable bond while living with Duchenne muscular dystrophy, a rare genetic disorder that causes progressive muscle weakness. - facebook.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.